Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Henderson's revenue in the first half of the year grew by 31%

7/10/24 HNFG

Samolet sales in the 1st half of the year increased by 42%

7/10/24 SMLT

Moscow Exchange has developed an insider trading index

7/10/24 MOEX

Raspadskaya reported for 6 months of 2024 by RAS

7/10/24 RASP

Exchange swap of Yandex shares completed

7/10/24 YNDX

Exchange swap of Yandex shares completed

7/10/24 YDEX

Yuzhuralzoloto reported for Q1 2024 by RAS

7/9/24 UGLD

China Copper may become Nornickel's partner in China

7/9/24 GMKN

KMZ reported for the months of 2024 by RAS

7/9/24 KMEZ

Sollers to relaunch former Isuzu site in Q4

7/9/24 SVAV